K. Hirth

K.
Peter Hirth was the founder of Plexxikon, Inc., founded in 2001, where the title held was Chief Executive Officer & Director in 2013.
Current jobs include Chairman at IO Biotech ApS; Director at KineMed, Inc. since 2013; Director at Iconic Therapeutics, Inc. since 2015; Director at Afferent Pharmaceuticals, Inc. since 2014; Director at Enterome SA since 2023; Director at Escient Pharmaceuticals, Inc. since 2019; Independent Director at Aligos Therapeutics, Inc. since 2018; Director at TRex Bio Ltd. since 2019; and Venture Partner at Wellington Partners GmbH since 2022.
Former jobs include Independent Chairman at IO Biotech, Inc. from 2016 to 2026; Director at Alios BioPharma, Inc.; Director at Kolltan Pharmaceuticals, Inc.; Independent Director at Vaxcyte, Inc. from 2016 to 2025; Director at Aria Biosystems Corp.; President at Sugen, Inc.; Vice President-Research at Roche Diagnostics GmbH; and Vice President-Research at Max-Planck-Institute for Molecular Genetics.
Education includes graduate and doctorate degrees from Ruprecht-Karls-Universität Heidelberg.